When to close a patent foramen ovale

Archives of Disease in Childhood

Volumn 93, Issue 3, 2008, Pages 255-259

  Kenny, D ^a   Turner, M ^a   Martin, R ^a  

^a BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIVING; HEART RIGHT LEFT SHUNT; HEART SURGERY; HUMAN; MIGRAINE; PATENT FORAMEN OVALE; PRIORITY JOURNAL; REVIEW; SHUNTING; STROKE; TRANSTHORACIC ECHOCARDIOGRAPHY; ADULT; CHILD; DECOMPRESSION SICKNESS; ECHOCARDIOGRAPHY; HEART; HEART ATRIUM FUNCTION; MIGRAINE WITH AURA; PATHOPHYSIOLOGY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; ATRIAL FUNCTION; CHILD; DECOMPRESSION SICKNESS; DIVING; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FORAMEN OVALE, PATENT; HEART; HUMANS; MIGRAINE WITH AURA; STROKE;

EID: 41749097265     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.110098     Document Type: Review

References (33)

1. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 2003;107:5-9.
2. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
3. Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation 2005;112:1063-72.
4. Windecker S, Wahl A, Nedeltchev K, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44:750-8.
5. Lausanne Stroke with Paradoxal Embolism Study Group. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Neurology 1996;46:1301-5.
6. Agnetti A, Carano N, Sani E, et al. Cryptogenic stroke in children: possible role of patent foramen ovale. Neuropediatrics 2006;37:53-6.
7. Chung B, Wong V. Pediatric Stroke Among Hong Kong Chinese Subjects. Pediatrics 2004;114:206-12.
8. de Veber G, Roach ES, Riela AR, et al. Stroke in children: recognition, treatment, and future directions. Semin Pediatr Neurol 2000;7:309-17.
9. Zahuranec DB, Brown DL, Lisabeth LD, et al. Is it time for a large, collaborative study of pediatric stroke? Stroke 2005;36:1825-29.
10. Kramer P. On horse sense and horse feathers: An argument against insistence on enrolling cryptogenic stroke patients with patent foramen ovale in randomized clinical trials. Catheter Cardiovasc Interv 2007;69:1-3.
11. Ganesan V, Prengler M, McShane MA, et al. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003;53:167-73.
12. Ganesan V, Prengler M, Wade A, et al. Clinical and radiological recurrence after childhood arterial ischemic stroke. Circulation 2006;114:2170-77.
13. Bartz PJ, Cetta F, Cabalka AK, et al. Paradoxical emboli in children and young adults: Role of atrial septal defect and patent foramen ovale device closure. Mayo Clin Proc 2006;81:615-8.
14. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 2003;139:753-60.
15. Butera G, Lucente M, Rosti L, et al. A comparison between the early and mid-term results of surgical as opposed to percutaneous closure of defects in the oval fossa in children less than 6 years. Cardiol Young 2007;17:35-41.
16. Mavromichalis I, Anagnostopoulos D, Metaxas N, et al. Prevalence of migraine in schoolchildren and some clinical comparisons between migraine with and without aura. Headache 1999;39:728-36.
17. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci 2001;100:215- 20.
18. Del Sette M, Angeli S, Leandri M, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case control study. Cerebrovasc Dis 1998;8:327-30.
19. Azarbal B, Tobis J, Suh W, et al. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 2005;45:489-92.
20. Giardini A, Donti A, Formigari R, et al. Transcatheter patent foramen ovale closure mitigates aura migraine headache abolishing spontaneous right-to-left shunting. Am Heart J 2006;151:922.e1-5.
21. Dowson A, Wilmshurst P, Mullen M, et al. A prospective, multicenter, randomized, double blind, placebo-controlled trial to evaluate the efficacy of patent foramen ovale closure with the STARFlex septal repair implant to prevent refractory migraine headaches: The MIST Trial. Presented at the American College of Cardiology, Atlanta, 2006.
22. Wilmshurst PT, Byrne JC, Webb-Peploe MM. Relation between, interartrial shunts and decompression sickness in divers. Lancet 1989;2:1302-6.
23. Wilmshurst P, Bryson P. Relationship between the clinical features of decompression illness and its causes. Clin Sci 2000;99:65-75.
24. Knauth M, Ries S, Pohimann S, et al. Cohort study of multiple brain lesions in sport divers: role of patent foramen ovale. BMJ 1997;314:701-5.
25. Wilmshurst PT, Pearson MJ, Nightingale S, et al. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004;90:1315-20.
26. Wilmshurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lncet 2000;356:1648-51.
27. Di Tullio M, Sacco RL, Venketasubramanian N, et al. Comparison of diagnostic techniques for the detection of patent foramen ovale in stroke patients. Stroke 1993;24:1020-4.
28. Lee TT, De la Torre R, Carrozza JP Jr. Suture-mediated closure of a patent foramen ovale during surgery without cardiopulmonary bypass. Catheter Cardiovasc Interv 2006;68:747-8.
29. Patel A, Cao QL, Koenig PR, et al. Intracardiac echocardiography to guide closure of atrial septal defects in children less than 15 kilograms. Catheter Cardiovasc Interv 2006;68:287-91.
30. Martin F, Sanchez PL, Doherty E, et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002;106:1121-6.
31. Braun M, Gliech V, Boscheri A, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 2004;25:424-30.
32. Cardenas L, Panzer J, Boshoff D, et al. Transcatheter closure of secundum atrial defect in small children. Catheter Cardiovasc Interv 2007;69:447-52.
33. Christen T, Mach F, Didier D, et al. Late cardiac tamponade after percutaneous closure of a patent foramen ovale. Eur J Echocardiogr 2005;6:465-9.